Prospective Analysis of Urine LAM to Eliminate NTM Sputum Screening

Launched by JERRY A. NICK, M.D. · Oct 1, 2020

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Informed consent obtained online or in person from the participant
• • Enrolled in the CFF Patient Registry (CFFPR)
• • Be willing and able to adhere to study procedures in the context of clinical care, and other protocol requirements
• • Diagnosis of CF consistent with the 2017 CFF Guidelines NTM culture status of negative (defined by a review of clinical and culture data with at least 3 years of clinical data available to review and at least one negative culture within the year prior to enrollment and no known history of previous positive cultures for pathogenic NTM)
• Exclusion Criteria:
• • 1. Has any other condition that, in the opinion of the Site Investigator/designee, would preclude informed consent or assent, make study participation unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives